Related references
Note: Only part of the references are listed.miR-141-3p commonly regulates human UGT1A isoforms via different mechanisms
Naoyuki Tatsumi et al.
DRUG METABOLISM AND PHARMACOKINETICS (2018)
Reduced gene expression of sirtuins and active AMPK levels in children and adolescents with obesity and insulin resistance
Zahra Arab Sadeghabadi et al.
OBESITY RESEARCH & CLINICAL PRACTICE (2018)
AMPK Re-Activation Suppresses Hepatic Steatosis but its Downregulation Does Not Promote Fatty Liver Development
Nadia Boudaba et al.
EBIOMEDICINE (2018)
MicroRNA-138 Aggravates Inflammatory Responses of Macrophages by Targeting SIRT1 and Regulating the NF-kappa B and AKT Pathways
Xiao-Zhi Bai et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2018)
Obesity-induced upregulation of miR-361-5p promotes hepatosteatosis through targeting Sirt1
Zhijian Zhang et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2018)
Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1
He-Nan Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Identification of miR-31-5p, miR-141-3p, miR-200c-3p, and GLT1 as human liver aging markers sensitive to donor-recipient age-mismatch in transplants
Miriam Capri et al.
AGING CELL (2017)
Nonalcoholic Fatty Liver Disease and Insulin Resistance: New Insights and Potential New Treatments
Hironori Kitade et al.
NUTRIENTS (2017)
The association between obesity related adipokines and risk of breast cancer: a meta-analysis
Yu Gui et al.
ONCOTARGET (2017)
Loss of miR-141/200c ameliorates hepatic steatosis and inflammation by reprogramming multiple signaling pathways in NASH
Melanie Tran et al.
JCI INSIGHT (2017)
MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1
Yunxia Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Non-alcoholic fatty liver disease: An expanded review
Mark Benedict et al.
WORLD JOURNAL OF HEPATOLOGY (2017)
MicroRNA-141 Targets Sirt1 and Inhibits Autophagy to Reduce HBV Replication
Ying Yang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
Sirtuin 1 Activation Alleviates Cholestatic Liver Injury in a Cholic Acid-Fed Mouse Model of Cholestasis
Supriya R. Kulkarni et al.
HEPATOLOGY (2016)
SIRT1 and insulin resistance
Yue Cao et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
SIRT1 Disruption in Human Fetal Hepatocytes Leads to Increased Accumulation of Glucose and Lipids
Takamasa Tobita et al.
PLOS ONE (2016)
Sirtuins and nonalcoholic fatty liver disease
Fatiha Nassir et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2016)
Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1
Ran Ao et al.
MEDICAL SCIENCE MONITOR (2016)
MicroRNAs as Biomarkers for Liver Disease and Hepatocellular Carcinoma
C. Nelson Hayes et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Differential expression of serum microRNAs in cirrhosis that evolve into hepatocellular carcinoma related to hepatitis B virus
Youwen Tan et al.
ONCOLOGY REPORTS (2015)
Plasma levels of SIRT1 associate with non-alcoholic fatty liver disease in obese patients
Stefania Mariani et al.
ENDOCRINE (2015)
Serum MicroRNAs as Potential Biomarkers of Primary Biliary Cirrhosis
Youwen Tan et al.
PLOS ONE (2014)
Dual Role of MicroRNAs in NAFLD
Sara Ceccarelli et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
SIRT1 in Type 2 Diabetes: Mechanisms and Therapeutic Potential
Munehiro Kitada et al.
DIABETES & METABOLISM JOURNAL (2013)
SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function
Nathan L. Price et al.
CELL METABOLISM (2012)
MicroRNAs in metabolism and metabolic disorders
Veerle Rottiers et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Uric Acid Stimulates Fructokinase and Accelerates Fructose Metabolism in the Development of Fatty Liver
Miguel A. Lanaspa et al.
PLOS ONE (2012)
Current therapeutic strategies in non-alcoholic fatty liver disease
J. K. Dowman et al.
DIABETES OBESITY & METABOLISM (2011)
MicroRNAs and liver disease
Thomas A. Kerr et al.
TRANSLATIONAL RESEARCH (2011)
microRNAs: Fad or future of liver disease
Ashley M. Lakner et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
AMPK and SIRT1: a long-standing partnership?
Neil B. Ruderman et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2010)
The widespread regulation of microRNA biogenesis, function and decay
Jacek Krol et al.
NATURE REVIEWS GENETICS (2010)
SIRT1 Regulation of Apoptosis of Human Chondrocytes
Koji Takayama et al.
ARTHRITIS AND RHEUMATISM (2009)
MiR-34, SIRT1 and p53 The feedback loop
Munekazu Yamakuchi et al.
CELL CYCLE (2009)
Hepatocyte-Specific Deletion of SIRT1 Alters Fatty Acid Metabolism and Results in Hepatic Steatosis and Inflammation
Aparna Purushotham et al.
CELL METABOLISM (2009)
SIRT1 Promotes Cell Survival under Stress by Deacetylation-Dependent Deactivation of Poly(ADP-Ribose) Polymerase 1
Senthilkumar B. Rajamohan et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
A three-dimensional view of the molecular machinery of RNA interference
Martin Jinek et al.
NATURE (2009)
SIRT1 regulates hepatocyte lipid metabolism through activating AMP-activated protein kinase
Xiuyun Hou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
SIRT1 promotes DNA repair activity and deacetylation of Ku70
Jaemin Jeong et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2007)
MicroRNAs: Genomics, biogenesis, mechanism, and function
DP Bartel
CELL (2004)
Minireview: The AMP-activated protein kinase cascade: The key sensor of cellular energy status
DG Hardie
ENDOCRINOLOGY (2003)
Share Paper
